Glassman Wealth Services’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Glassman Wealth Services’s Portfolio VAXX Stock Details VAXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,386	Closed	-$2.03K	–	1957
2023 Q4	$2.03K	Hold	2,386	–	–	﹤0.01%	1340
2023 Q3	$3.27K	Hold	2,386	–	–	﹤0.01%	1190
2023 Q2	$6.01K	Hold	2,386	–	–	﹤0.01%	943
2023 Q1	$5.42K	Hold	2,386	–	–	﹤0.01%	977
2022 Q4	$3.34K	Hold	2,386	–	–	﹤0.01%	1135
2022 Q3	$5K	Hold	2,386	–	–	﹤0.01%	1021
2022 Q2	$4K	Buy	+2,386	New	+$9.02K	﹤0.01%	1104

Other funds holding VAXX

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

SAS

Stelac Advisory Services New York $494M AUM 23.25% 1-Year Est. Return

Glassman Wealth Services's VAXX Position: Q1 2024 in Review

Glassman Wealth Services sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q1 2024, closing a stake of 2,386 shares — an estimated $2.03K sold.

Glassman Wealth Services first reported a position in VAXX in Q2 2022 and held it in 7 quarters. The position peaked at $6.01K in Q2 2023. 58 funds tracked by Wall St. Rank hold VAXX as of Q1 2024.

Glassman Wealth Services reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
Glassman Wealth Services sold 2,386 Vaxxinity, Inc. Class A Common Stock shares in Q1 2024, an estimated $2.03K.
Glassman Wealth Services first reported a position in Vaxxinity, Inc. Class A Common Stock in Q2 2022 and held it in 7 quarters.
Glassman Wealth Services's Vaxxinity, Inc. Class A Common Stock position peaked at $6.01K in Q2 2023.
58 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.